Register Login

Dabigatran Cleared by FDA

The oral direct thrombin inhibitor Dabigatran, (Boehringer-Ingelheim, Pradaxa®) was cleared Tuesday, October 19 for stroke prevention in atrial fibrillation. Dabigatran is the first of the new generation of oral anticoagulants to be released to the market. The press release from Boehringer is attached.

Pradaxa Press Release 10-19-10

Comments (0)

No comments here.

Leave a Reply